News & Media
Archives
-
Jan 12 2018Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2018 on February 8 prior to the opening of trading on the New York Stock Exchange. The company...
Jan 11 2018Deliverability of EluNIR™ stent in complex patient anatomy demonstrated during first commercial cases at Columbia University Medical Center and Piedmont Heart InstituteDUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States...
-
Jan 04 2018Cardinal Health announced today that Mike Kaufmann, chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 8, 2018, at 11 a.m....
Dec 07 2017Growing interest in biosimilars, caution about CAR T, and increased use of genetic testing for AML patients are among the key findings.Cardinal Health Specialty Solutions today introduced the second edition of Oncology Insights, a research-based report outlining the views of more than 200 U.S. oncologists on the latest medical...
Nov 30 2017EluNIR is shown to effectively treat highly complex disease with optimized stent and delivery systemCordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients...
-
Nov 16 2017Company to Collaborate with Key Partners across Ohio, Kentucky, Tennessee and West VirginiaCardinal Health (NYSE: CAH) today launched its new Opioid Action Program, aimed at helping communities in four of the nation's hardest-hit states across Appalachia combat the opioid epidemic. The...
-
Nov 14 2017Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma")...
Nov 14 2017Cardinal Health earns 100 percent on Human Rights Campaign Foundation's annual scorecard for tenth consecutive yearAs an organization that believes cultivating a diverse and inclusive work environment is crucial to corporate success, Cardinal Health earned a perfect score on the 2018 Corporate Equality Index...
-
Nov 08 2017Cardinal Health (NYSE: CAH) today announced that the board of directors approved a regular quarterly dividend of $0.4624 per share, payable Jan. 15, 2018, to shareholders of record on Jan. 2,...
Nov 06 2017-- Mike Kaufmann Named Chief Executive Officer, Effective January 1, 2018 --Cardinal Health (NYSE: CAH) announced today that it has named Mike Kaufmann, 54, its current chief financial officer, to serve as the company's next chief executive officer and join the board of...
Get news alerts by email
Complete the form below to receive e-mail notifications of our news releases. You will receive an email which you must reply to in order to confirm your subscription. You may unsubscribe from our list at anytime.